SemBioSys is a development stage agricultural biotechnology company that utilizes its patented plant seed based oilbody and genetic expression technology platforms to develop high value proteins and oils, and drug candidates in oil seed producing plant species. SemBioSys is working on solutions that target diabetes (insulin) and cardiovascular disease (Apo AIMilano), and applying the technology to nutritional supplements, functional food ingredients, and agricultural biotechnology products.